What we’ve achieved
HPP initiated the Thought Leadership Forum on Cardiovascular Disease in 2022. The project is advised by a multidisciplinary group of senior stakeholders seeking to ignite greater political urgency in CVD. It was established to stimulate new strategic debates in CVD to ultimately accelerate policy leadership and health system transformation in the societal interest.
This programme of work has been initiated with the publication of a discussion paper, Making the case for political urgency in cardiovascular disease. The paper provides the context and rationale for this work and a public statement of intent. It focuses on four types of CVD: atherosclerotic CVD, atrial fibrillation, heart failure and heart valve disease.
In July 2022, we published a think piece, Finding inspiration within prominent national cardiovascular disease plans, aiming to establish a clearer picture of existing strategic responses to CVD by national governments. We identified nine prominent examples of national CVD plans and explored the common themes within them, highlighting areas of inspiration.
This was followed by a second think piece, The heart of society: why addressing cardiovascular disease is critical to achieving wider societal goals, published in September 2022. The think piece seeks to address a major knowledge gap by exploring the links between CVD and wider societal priorities such as: healthy ageing and economic growth, COVID-19 recovery and health system resilience, and health inequalities.
In November 2022, we hosted a webinar based on the themes of the two think pieces. The event – ‘A new future for cardiovascular health: how do we unite decision-makers behind the next generation of national CVD plans?’ – featured speakers from the CVD community and beyond, considering how best to make the case to governments that a strong response to CVD is essential. At the event, we launched an action statement summarising key findings from the Thought Leadership Forum on Cardiovascular Disease and highlighting progressive actions to shape the future of CVD policy in Europe.
To find out more about the Thought Leadership Forum on Cardiovascular Disease, please contact us at CVDTLF@hpolicy.com